Search Results 2231-2240 of 21980 for magnesiummagnesium

  1. Cetirizine (intravenous route) - Side effects & uses - Mayo Clinic

    Cetirizine injection is used to treat adults and children 6 months of age and older with acute urticaria (hives, itching, or redness of the skin). Cetirizine is ...

  2. Study to Evaluate the Effects of Vitamin B3 Derivative on Bone, Skeletal, Muscle and Metabolic Functions in Aging - Mayo Clinic

    Subject who takes multivitamins containing vitamin B3 derivatives in a dose > 200 mg/day. ... Serum phosphorus > 5 mg/dL. Serum alkaline phosphatase 50 ...

  3. Salicylic acid and sulfur (topical route) - Side effects & dosage - Mayo Clinic

    Choline Magnesium Trisalicylate; Choline Salicylate; Cilostazol; Citalopram; Clomipramine; Clonixin; Clopamide; Clopidogrel; Cyclopenthiazide; Cyclosporine ...

  4. Infectious Diseases! Clinical Trials - Mayo Clinic Research

    Additionally, to evaluate the effectiveness, as determined by 90-day mortality and 28-day mortality with or without transplant for IV DUR-928 (30 mg or 90 mg) ...

  5. Publications - Lopa Misra, D.O. - Mayo Clinic

    Lopez-Ruiz AA, Trinchet LP, Morozowich S, Misra L. The Efficacy of Magnesium Sulfate in Perioperative Multimodal Analgesia. ... Bolus-Dose Fospropofol Disodium ( ...

  6. Publications - Jose M. Soto Soto, M.D. - Mayo Clinic

    Festic E, Soto JS, Pitre LA, Leveton M, Ramsey DM, Freeman WD, Heckman MG, Lee AS. Novel Bedside Phonetic Evaluation to Identify Dysphagia and Aspiration Risk.

  7. A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma - Mayo Clinic

    ... (mg/L) (via local or central laboratory assessment) or 2) high risk ... (mg)/24 hours * Light chain multiple myeloma in whom only measurable disease is ...

  8. Acetylcysteine (inhalation route) - Mayo Clinic

    Acetylcysteine is used for certain lung conditions when increased amounts of mucus make breathing difficult. Acetylcysteine liquefies (thins) or dissolves mucus ...

  9. Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients with Dumping Syndrome - Mayo Clinic

    Serum creatinine >2.0 mg/dL; Alkaline phosphatase >2.5 x ULN; Serum total ... Magnesium < 0.7 mEq/L. Participation in any clinical investigation within 4 ...

  10. Ph 1b Study to Evaluate GSK2110183 in Combination with Bortezomib and Dexamethasone in Subjects with Multiple Myeloma - Mayo Clinic

    Schedule A - GSK2110183 administered once daily with bortezomib (1.3 mg/m2) and dexamethasone (20 mg) given biweekly. Part 2 will further explore the safety ...